BCR-ABL rearrangement and HLA antigens: a possible link to leukemia pathogenesis and immunotherapy

Giunta, Marina; Pucillo, Carlo.
Rev. bras. hematol. hemoter ; 34(5): 323-324, 2012.
Artículo en Inglés | LILACS | ID: lil-654967

Documentos relacionados

  1. Variable characteristics overlooked in human K-562 leukemia cell lines with a common signature.
  2. MicroRNA miR-125b causes leukemia.
  3. The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy.
  4. Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis.
  5. [Clinical Characteristics of Patients with Ph<sup>+</sup> Mixed Phenotype Acute Leukemia].
  6. Ponatinib and platelets a conflict in CML.
  7. Synthetic Reprogramming of Kinases Expands Cellular Activities of Proteins.
  8. Overcoming the imatinib-resistant BCR-ABL mutants with new ureidobenzothiazole chemotypes endowed with potent and broad-spectrum anticancer activity.
  9. <i>De Novo</i> Linear Phosphorylation Site Motifs for BCR-ABL Kinase Revealed by Phospho-Proteomics in Yeast.
  10. The structural basis of BCR-ABL recruitment of GRB2 in chronic myelogenous leukemia.